Advertisement Press Releases Archive - Page 135 of 231 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pressreleases

Search

  • 27 Feb 2013
    CROMSOURCE Announces Industry Leading Timeline and Budget Guarantee

    CROMSOURCE Announces Industry Leading Timeline and Budget Guarantee

    By admin

    CROMSOURCE, an international full service contract research organization (CRO), today announced a unique alternative to the routine delays and budget escalations which characterise the delivery of clinical trials. CROMSOURCE now offers clients the industry's only End-to-End Guarantee. Within this pledge CROMSOURCE assures clients that their projects will be delivered according to the contracted timelines and to the price written on the contract.

  • 26 Feb 2013
  • 26 Feb 2013
    Worldwide Clinical Trials Receives Recognition From ISR; The CRO to Have on Your “Radar”

    Worldwide Clinical Trials Receives Recognition From ISR; The CRO to Have on Your “Radar”

    By admin

    Worldwide Clinical Trials Inc, today acknowledged receipt of strong ratings and recommendations from one of the industry’s leading independent market research firms, Industry Standard Research (ISR). In ISR’s recently published, ‘2012 CRO Quality Benchmarking Report’, CROs (Clinical Research Organisations) were quantitatively assessed for delivery strengths and weaknesses. Sponsors' selection drivers, outsourcing volume, and provider preferences were also measured.

  • 26 Feb 2013
  • 24 Feb 2013
  • 21 Feb 2013
    New Member Added to KT Series of Refrigerated Incubators

    New Member Added to KT Series of Refrigerated Incubators

    By admin

    Refrigerated incubators create a constant microclimate for the development and growth processes of microorganisms and cell cultures. They are part of every laboratory where cell biology, microbiology or molecular biology methods are used in biology, medicine, pharmaceutical research or the food industry.

  • 21 Feb 2013
    SHL to invest 40 Million USD in 2013 to Significantly Expand Production Facilities

    SHL to invest 40 Million USD in 2013 to Significantly Expand Production Facilities

    By admin

    SHL announced plans this week to expand production facilities in Taiwan. A leader in the field of drug delivery devices such as auto injectors and pen injectors, SHL has continued to invest heavily in facilities, advanced machinery and R&D. With the rapid growth of the biologic injectable market, device suppliers are under pressure to broaden the range of services that they can provide. SHL has responded by making significant capital investments such as the 40 Million USD that will be spent this year alone.

  • 21 Feb 2013
    Aptuit Announces Formation Of Scientific Advisory Board

    Aptuit Announces Formation Of Scientific Advisory Board

    By admin

    Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced that the company has formed the Aptuit Scientific Advisory Board (SAB) comprised of scientific experts from within the company. The SAB will regularly meet to assess Aptuit's current and long term scientific capabilities and objectives and will recommend actions.

  • 14 Feb 2013
  • 14 Feb 2013
    Aptalis Pharmaceutical Technologies Expands Licensing Team

    Aptalis Pharmaceutical Technologies Expands Licensing Team

    By admin

    Aptalis Pharmaceutical Technologies, a business unit of Aptalis Pharma that develops differentiated products utilizing its oral delivery technologies, today announces that Nigel Ray has been named as the company’s Vice President of Global Licensing.

«‹133134135136137›»